CSPC Pharmaceutical Group (FRA:CVG) 1-Year Share Buyback Ratio : 2.10% (As of Sep. 2024 )

View and export this data going back to . Start your Free Trial

What is CSPC Pharmaceutical Group 1-Year Share Buyback Ratio?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

1-Year Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past year, calculated as the percentage change in shares outstanding from the previous year to the current year. A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance. CSPC Pharmaceutical Group's current 1-Year Share Buyback Ratio was 2.10%.

FRA:CVG's 1-Year Share Buyback Ratio is ranked better than
92.59% of 540 companies
in the Drug Manufacturers industry
Industry Median: -1.7 vs FRA:CVG: 2.10

Competitive Comparison of CSPC Pharmaceutical Group's 1-Year Share Buyback Ratio

For the Drug Manufacturers - General subindustry, CSPC Pharmaceutical Group's 1-Year Share Buyback Ratio, along with its competitors' market caps and 1-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CSPC Pharmaceutical Group's 1-Year Share Buyback Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CSPC Pharmaceutical Group's 1-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where CSPC Pharmaceutical Group's 1-Year Share Buyback Ratio falls into.

Save Embed

;

Save Embed

;

CSPC Pharmaceutical Group 1-Year Share Buyback Ratio Calculation

CSPC Pharmaceutical Group's 1-Year Share Buyback Ratio for the quarter that ended in Sep. 2024 is calculated as

1-Year Share Buyback Ratio	=	(Shares Outstanding (EOP) (Sep. 2023 )	-	Shares Outstanding (EOP) (Sep. 2024 ))	/	Shares Outstanding (EOP) (Sep. 2023 )
	=	(11848.756	-	11595.882)	/	11848.756
	=	2.1%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CSPC Pharmaceutical Group (FRA:CVG) 1-Year Share Buyback Ratio Explanation

A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

CSPC Pharmaceutical Group 1-Year Share Buyback Ratio Related Terms

CSPC Pharmaceutical Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CSPC Pharmaceutical Group Ltd (FRA:CVG) » Definitions » 1-Year Share Buyback Ratio

Comparable Companies

Traded in Other Exchanges

CSPCY:USA CHJTF:USA 01093:Hong Kong CVG:Germany

Address

No. 226 Huanghe Street, Hebei Province, Shijiazhuang, CHN, 050035

Website

https://www.cspc.com.hk

CSPC Pharmaceutical Group listed on the Hong Kong Stock Exchange in 1994 and is one of the largest pharmaceutical companies in China. Its biggest business segment is the finished drugs segment which accounts for nearly 80% of its total revenue. Now it has a diversified pipeline portfolio in seven therapeutic areas including nervous system diseases, oncology, anti-infective to cardiovascular disease, respiratory system disease, and metabolism. CSPC also has a bulk drug product segment including vitamin C and antibiotics.